JWH-250 4-Hydroxypentyl metabolite-D5 (indole-D5)

Description

 RESTRICTED PRODUCT 

Schedule 9 (S9) Licence required.

This product requires an Australian government issued permit to hold or possess.

An internal standard suitable for quantitation of JWH-250 4-Hydroxypentyl metabolite in biological matrices such as urine for LC/MS or GC/MS testing applications in clinical toxicology, forensic analysis, or urine drug testing. This monohydroxy analog is a primary urinary metabolite of JWH-250, a synthetic cannabinoid found in several blends of the herbal mixture Spice. The biomarker is also referred to as the omega-1 hydroxy metabolite of JWH-250. For those synthetic cannabinoids currently controlled at the federal level, our certified solution standards of these substances are DEA-exempt, allowing laboratories to place orders without additional regulatory paperwork. For US customers, state specific regulatory requirements may apply.